Apyx Medical Corporation (APYX) Dividend History

Apyx Medical Corporation (APYX) develops and markets medical devices, primarily focusing on advanced tissue and nerve ablation techniques. The company's flagship product, Renuvion/JPlasma, uses cold plasma technology for cosmetic skin tightening, body contouring, and minimally invasive surgical procedures, promoting tissue coagulation and rejuvenation. Apyx aims to enhance aesthetic and surgical outcomes through innovative energy-based platforms.

5115 Ulmerton Road, Clearwater, FL, 33760
Phone: (727) 384-2323
Website:

Dividend History

Apyx Medical Corporation currently does not pay dividends

Company News

  • Apyx Medical Corporation received FDA clearance for its AYON Body Contouring System, which combines multiple technologies for body contouring procedures. The company plans to launch the system with key surgeons in the second half of 2025.

    GlobeNewswire Inc.
  • Apyx Medical Corporation has submitted a 510(k) premarket notification to the FDA for its AYON Body Contouring System, which is designed to provide comprehensive body contouring solutions through an all-in-one platform.

    GlobeNewswire Inc.
  • Butterfly Network's stock surged 26.9% after the company announced the commercial launch of its third-generation handheld point-of-care ultrasound system, Butterfly iQ3, in Europe. The device's strong uptake in the U.S. market and its advanced features are driving investor optimism.

    Benzinga
    Featured Companies: BFLY BSX UHS
  • Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: MDT
  • U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.77% to 39,814.95 while the NASDAQ rose 0.25% to 16,410.54. The S&P 500 also rose, gaining, 0.38% to 5,244.72. Check This Out: Micron, Accenture And 3 Stocks To Watch Heading Into Thursday   Leading and Lagging Sectors   Industrials shares jumped by 1% on Thursday. In trading on Thursday, materials shares rose by just 0.1%.   Top Headline   Shares of Accenture Plc (NYSE: ACN) dipped around 9% on Thursday after the company reported results for its fiscal second quarter. Accenture reported second-quarter fiscal 2024 sales of $15.80 billion compared with the consensus of $15.84 billion, flat Y/Y in U.S. dollars and local currency. Revenues were slightly above the midpoint of the company’s guided range of $15.40 billion – $16.00 billion. Adjusted EPS of $2.77 beat the consensus of $2.66. Accenture expects fiscal 2024 adjusted EPS of $11.97 – $12.20 (prior $11.97 – $12.32) versus consensus of $12.24. For fiscal 2024, the company expects revenue growth of 1% – 3% (prior 2% – 5%) in local currency vs. $66.18 billion consensus.   Equities Trading UP   Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares shot up 70% to $0.4124 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States. Shares of CuriosityStream Inc. (NASDAQ: CURI) got a boost, surging 56% to $0.91 ...

    Benzinga
    Featured Companies: ACN CURI SPIR
Dividend data last updated 06/07/2025 00:37:23 UTC